ERBB2 and breast carcinoma: The breast carcinomas we studied from MMR gene mutation carriers were predominantly ductal, ER- and PR-positive and HER2-negative, resembling breast carcinomas from non-carriers (Table 1) and those from the unselected Finnish population [33,41].